High factor VIII levels as a risk factor for thrombosis;Hoge concentratie van stollingsfactor VIII als risicofactor voor trombose

Nederlands Tijdschrift voor Geneeskunde

Volumn 145, Issue 46, 2001, Pages 2213-2217

  Kamphuisen, P W ^a   Eikenboom, H C J ^a   Rosendaal, F R ^a   Bertina, R M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8;

GENETIC PREDISPOSITION; HUMAN; HYPERCOAGULABILITY; MASS SCREENING; REVIEW; RISK ASSESSMENT; THROMBOSIS; VEIN THROMBOSIS;

CASE-CONTROL STUDIES; FACTOR VIII; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MASS SCREENING; NETHERLANDS; PRACTICE GUIDELINES; PREVALENCE; RISK FACTORS; VENOUS THROMBOSIS;

EID: 0035904654     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis
2. High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: Role of increased synthesis and relationship to the acute phase reaction
3. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism
4. Venous thromboembolic disease and ABO blood type. A cooperative study
5. Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions
6. High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand and factor VIII gene
7. Elevation of FVIII:C in venous thromboembolism is persistent and independent of the acute phase response
8. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism
9. Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study
10. Prospective study of hemostatic factors and incidence of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study
11. Factor VIII, ABO blood group and the incidence of ischaemic heart disease
12. Haemophilia protects against ischaemic heart disease: A study of risk factors
13. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families
14. Apparent different thrombotic tendency in patients with factor V Leiden and protein C deficiency due to selection of patients
15. High factor VIII levels contribute to the thrombotic risk in families with factor V Leiden
16. Venous thrombosis, oral contraceptives and high factor VIII levels
17. A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis
18. Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia
19. Familial clustering of high factor VIII levels in patients with venous thromboembolism
20. Analysis of the F8 gene in individuals with high plasma factor VIII:C levels and associated venous thrombosis
21. Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level
22. The half-life of infused factor VIII is shorter in hemophiliac patients with blood group O than in those with blood group A
23. Prospective study of markers of hemostatic function with risk of ischemic stroke
24. The basis for the increase in factor VIII procoagulant activity during exercise
25. Vasopressin-induced von Willebrand factor secretion from endothelial cells involve V2 receptors and cAMP
26. The measurement of haemostatic factors in 16 European laboratories: Quality assessment for the Multicentre ECAT Angina Pectoris Study. Report from the European Concerted Action on Thrombosis and Disabilities (ECAT)